[HTML][HTML] Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage …
L Yang, C Tang, B Xu, W Wang, J Li, X Li, H Qin… - PLoS …, 2015 - journals.plos.org
Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
[PDF][PDF] Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB …
L Yang, C Tang, B Xu, W Wang, J Li, X Li - PLoS ONE, 2015 - Citeseer
Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
[PDF][PDF] Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB …
L Yang, C Tang, B Xu, W Wang, J Li, X Li - PLoS ONE, 2015 - scienceopen.com
Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV …
L Yang, C Tang, B Xu, W Wang, J Li, X Li, H Qin, H Gao… - Plos one, 2015 - europepmc.org
Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV …
L Yang, C Tang, B Xu, W Wang, J Li, X Li, H Qin… - PloS …, 2015 - pubmed.ncbi.nlm.nih.gov
Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
[引用][C] Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB …
L Yang, C Tang, B Xu, W Wang, J Li, X Li, H Qin… - PLoS …, 2015 - ui.adsabs.harvard.edu
Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum
Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell …
Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell …
Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV …
L Yang, C Tang, B Xu, W Wang, J Li, X Li, H Qin, H Gao… - PLoS ONE, 2015 - go.gale.com
Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
[HTML][HTML] Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage …
L Yang, C Tang, B Xu, W Wang, J Li, X Li, H Qin… - PLoS ONE, 2015 - ncbi.nlm.nih.gov
Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
[PDF][PDF] Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB …
L Yang, C Tang, B Xu, W Wang, J Li, X Li - PLoS ONE, 2015 - pdfs.semanticscholar.org
Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV …
L Yang, C Tang, B Xu, W Wang, J Li, X Li, H Qin… - PLoS …, 2015 - search.ebscohost.com
Objectives: Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …
response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer …